1 / 2

Europe Cryochambers

Cryotherapy is an approach that uses a method of localized freezing temperatures to deaden an irritated nerve. It finds application in the treatment of localized areas of some cancers and in diseases related to skin.

Download Presentation

Europe Cryochambers

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Coherent Market Insights The cryochambers sector in Europe is continuing to grow, with new uses in the treatment of injuries and infections prior to surgery Cryotherapy has become very popular as a way for cold and viral decrease, especially after the COVid-19 global pandemic. Reducing inflammation, enhancing metabolism and reduction of fatigue and chronic pain are among the many beneficial advantages of cryochamber therapy that will most likely continue to push the use of Europe cryochambers everywhere around the globe. Many diseases such as chronic fatigue syndrome and Fibromyalgia have responded well to the use of cryotherapy. There are numerous reports of successful clinical trials conducted with patients suffering from cancer, arthritis, and other degenerative diseases. Europe cryochambers have been used since the year 2021. The Cryotherapy Association Europe has taken over the regulation of the industry and is currently undergoing a process of revising the scope of applications for cryochamber therapy throughout the continent. The first company to introduce the procedure to the rest of Europe was Cogent Europe Limited, which is based in Coherent Market Insights

  2. Coherent Market Insights Solothurn, Cumbria. They were the first cryochamber manufacturer in Europe to produce an injection version, the C-Class, which they marketed under its own brand name, Spectra Cryo. Spectra Cryochamber was introduced in the U.K. in 2021. The first year saw the introduction of seven new applications across the country. These seven applications dealt with sports injuries, pre-surgical infections, post-surgical infections, multiple person infections, sepsis due to blood loss, musculoskeletal problems caused due to fractures, and vascular disorders. Each of these has had very positive results. Sports injuries have tended to be the most popular area for Europe cryochambers as this is the most common cause of major morbidity and mortality within clinical medicine today. Read More : https://bit.ly/3iZcNmu Coherent Market Insights

More Related